Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Hussein H Khachfe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Pancreaticoduodenectomy (PD) remains the only curative option for patients with pancreatic adenocarcinoma (PDAC). Infectious complications (IC) can negatively impact patient outcomes and delay adjuvant therapy in most patients. This study aims to determine IC effect on overall survival (OS) following PD for PDAC. Study Design Patients who underwent PD for PDAC between 2010 and 2020 were identified from a single institutional database. Patients were categorized into two groups based on whether they experienced IC or not. The relationship between postoperative IC and OS was investigated using Kaplan−Meier and Cox‐regression multivariate analysis.
Results
Among 655 patients who underwent PD for PDAC, 197 (30%) experienced a postoperative IC. Superficial wound infection was the most common type of infectious complication ( n = 125, 63.4%). Patients with IC had significantly more minor complications (Clavien‐Dindo [CD] < 3; [59.4% vs. 40.2%, p < 0.001]), major complications (CD ≥ 3; [37.6% vs. 18.8%, p < 0.001]), prolonged LOS (47.2% vs 20.3%, p < 0.001), biochemical leak (6.1% vs. 2.8%, p = 0.046), postoperative bleeding (4.1% vs. 1.3%, p = 0.026) and reoperation (9.6% vs. 2.2%, p < 0.001). Time to adjuvant chemotherapy was delayed in patients with IC versus those without (10 vs. 8 weeks, p < 0.001). Median OS for patients who experienced no complication, noninfectious complication, and infectious complication was 33.3 months, 29.06 months, and 27.58 months respectively ( p = 0.023). On multivariate analysis, postoperative IC were an independent predictor of worse OS (HR 1.32, p = 0.049).
Conclusions
IC following PD for PDAC independently predict worse oncologic outcomes. Thus, efforts to prevent and manage IC should be a priority in the care of patients undergoing PD for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Surgery, Division of Surgical Oncology, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Alessandro Paniccia
Zitieren
APA
Khachfe, H. H., Hammad, A. Y., AlMasri, S., Nassour, I., ElAsmar, R., Liu, H., de Silva, A., Kraftician, J., Lee, K. K., Zureikat, A. H., & Paniccia, A. (2024). Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27595
Vancouver
Khachfe HH, Hammad AY, AlMasri S, Nassour I, ElAsmar R, Liu H, et al. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27595
BibTeX
@article{Khachfe2024,
author = {Khachfe, Hussein H and Hammad, Abdulrahman Y and AlMasri, Samer and Nassour, Ibrahim and ElAsmar, Rudy and Liu, Hao and de Silva, Annissa and Kraftician, Jasmine and Lee, Kenneth K and Zureikat, Amer H and Paniccia, Alessandro},
title = {Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27595}
}
EUVIMED